Hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic.
| This week's Fierce LifeSci is brought to you by Rho.
Trouble viewing? Click here.
|
| | Wednesday, May 19, 2021 | 1pm ET / 10am PT | |
|
|
| | | UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. |
|---|
| |
|
|
| | | Topics include: Challenges this team overcame during program execution Real-world solutions to keep your program on-track during COVID-19 Insights for productive collaboration between Sponsors and CROs |
|---|
| |
|
|
| | You are currently subscribed as [email protected]
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2020 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. | |
|
|
